Article

Financial Times on 2023-01-22 22:12

Chinese business & finance: China’s drug-pricing policy impedes biotech profits

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

China

Related news

Chinese business & finance: Global investment banks’ profits drop in China Financial Times
China
FHealthcare: China’s biotech boom ft.com
China
Chinese business & finance: China bond trades hit by suspension of pricing data Financial Times
China
Congress Targets China’s Biotech Ambitions wsj.com
China , San Francisco
CATL: China’s CATL delivers record profits despite doubts over US plans Financial Times
Texas , Saudi Arabia , China
South Korean business & finance: South Korean biotech companies seek to diversify from China as US tensions rise Financial Times
Free Trade , China , South Korea
Chinese business & finance: China’s top tech dealmaker Bao Fan goes missing Financial Times
China
Chinese business & finance: China’s largest auction houses plan to take on western rivals Financial Times
China
Chinese business & finance: China’s billionaires pay the price for Xi’s Covid crackdown Financial Times
China
Chinese business & finance: Cross-border debt boom aids China’s efforts to widen renminbi use Financial Times
China
Chinese business & finance: China’s property revival plan threatened by stand-off over old neighbourhoods Financial Times
China
Chinese business & finance: ‘What’s the point of buying?’ China’s property woes push young to rent Financial Times
China
Chinese business & finance: China’s zero-Covid retreat sparks wealth management product sell-off Financial Times
China
Chinese business & finance: Explainer. ‘High expectations’: What China’s reopening means for markets Financial Times
China
Chinese business & finance: China’s baijiu makers risk hangover from liquor glut despite new year’s binge Financial Times
China
Chinese business & finance: China’s financial sector rocked by expansion of anti-corruption drive Financial Times
China
Chinese business & finance: Nikkei Asia. China’s wealth management sector reels from ‘crisis of confidence’Financial Times
China , Asia
Chinese business & finance: opinion content. Inside Business. China’s corporate woes are narrower than ‘Japanification’ fears Financial Times
China
Chinese business & finance: Beijing struggles to revive China’s paralysed property market Financial Times
China , Beijing
Chinese business & finance: China’s billionaires back Xi’s plan to restore economy Financial Times
China